Date published:
April 23, 2019

Breakthrough in the attempt to miniaturize the Sencell Glucose Sensor

Lifecare is developing an implantable continuous glucose sensor based on its proprietary osmotic pressure cell technology.

One core element of the glucose sensor is a pressure transducer, which translates the glucose-induced osmotic pressure change in the measurement chamber into a transmittable electronic signal. Until now, the size of the pressure transducer prevented further miniaturization of the osmotic pressure chamber and of the final device.

Other publications

Date published:
November 22, 2020

Lifecare AS enhances its board with diabetes-, technology- and M&A experience

Read more
Date published:
November 12, 2020

Lifecare presents scientific update at the annual Diabetes Technology Meeting

Read more
Date published:
November 10, 2020

Rune Frisvold has resigned as Lifecare COO and is no longer affiliated with the company.

Read more